AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases Read more
Prothena and Novo Nordisk announce acquisition agreement for Prothena’s ATTR amyloidosis programme Read more
Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma Read more
J&J Reaches Opioid Settlement Agreement with New York State Consistent with Terms of Previously Announced Broader Settlement Agreement in Principle Read more
FDA accepts application for Roche’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD) Read more
GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations Read more
Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19 Read more